Giredestrant significantly improved IDFS over SOC endocrine therapy, reducing the risk of invasive disease recurrence or ...

HeartBeam shares rise after FDA clears its 12-lead ECG software, boosting plans for a 2026 launch and expanded cardiac ...

People with epilepsy are at risk for hypertension, atrial fibrillation, and hyperlipidemia; they also have an elevated risk ...

I am, after all, the fun mum — I can't shake the feeling that when it comes to serious mothering, I'm the spare. Her back-up ...

Bradycardia, a slow heartbeat under 60 bpm, can signal health concerns. Cardiologist Dr Kumar highlights risk factors, such as age and existing conditions.

Arvinas shows strong ESR1-mutant data with limited scope, niche SERD competition, Pfizer uncertainty, and a high-risk pipeline. See why ARVN stock is a hold.